Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Yoshiko Hashii"'
Autor:
Toshinari Yagi, MD, Osamu Suzuki, PhD, Haruki Matsuoka, MD, Kei Shinyashiki, MD, Toru Wakamatsu, MD, PhD, Hironari Tamiya, MD, PhD, Rie Suzuki, MD, Shigeki Kakunaga, MD, PhD, Satoshi Takenaka, MD, PhD, Yoshiko Hashii, MD, PhD, Ken-ichi Yoshida, MD, PhD, Katsuyuki Nakanishi, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 7, Pp 2674-2678 (2024)
EWSR1-PATZ1 fusion sarcoma is a type of round-cell sarcoma with EWSR1-non-EST fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors. In general, local disease is managed via surgical res
Externí odkaz:
https://doaj.org/article/7451f342d3634b079c3469a7edd10bb5
Autor:
Hisashi Ishida, Toshihiko Imamura, Ryoji Kobayashi, Yoshiko Hashii, Takao Deguchi, Takako Miyamura, Megumi Oda, Masaki Yamamoto, Keiko Okada, Hideki Sano, Katsuyoshi Koh, Yuki Yuza, Kenichiro Watanabe, Noriyuki Nishimura, Tetsuya Takimoto, Akiko Moriya‐Saito, Masahiro Sekimizu, Souichi Suenobu, Shosuke Sunami, Keizo Horibe
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Asparaginase is essential for treating T‐cell acute lymphoblastic leukemia (T‐ALL). Despite the ongoing debate on whether T‐ALL and T‐cell lymphoblastic lymphoma (T‐LBL) are the same disease entity or two distinct diseas
Externí odkaz:
https://doaj.org/article/281b826416d845c9b4a6119f4b9e9d3b
Autor:
Hikaru Minagawa, Yoshiko Hashii, Hiroko Nakajima, Fumihiro Fujiki, Soyoko Morimoto, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Akihiro Tsuboi, Keiichi Ozono
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background A Wilms’ tumor 1 (WT1) oral vaccine, Bifidobacterium longum (B. longum) 420, in which the bacterium is used as a vector for WT1 protein, triggers immune responses through cellular immunity consisting of cytotoxic T lymphocytes (
Externí odkaz:
https://doaj.org/article/530ac44263ef437fa04cd0dcba8fa563
Autor:
Hisashi Ishida, Shin-ichi Tsujimoto, Daisuke Hasegawa, Hirotoshi Sakaguchi, Shohei Yamamoto, Masakatsu Yanagimachi, Katsuyoshi Koh, Akihiro Watanabe, Asahito Hama, Yuko Cho, Kenichiro Watanabe, Maiko Noguchi, Masanobu Takeuchi, Junko Takita, Kana Washio, Keisuke Kato, Takashi Koike, Yoshiko Hashii, Ken Tabuchi, Moeko Hino, Yoshiko Atsuta, Yasuhiro Okamoto
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/fdbfc4409600419fb649625f0f484d67
Autor:
Tomoyuki Otsuka, Yoshiko Hashii, Sei Murayama, Yasunobu Ishizuka, Yoshiki Kojitani, Minako Nishio, Toshihiro Kudo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Pembrolizumab, an anti-programmed death-1 (PD-1) receptor monoclonal antibody, is an effective first-line therapy for metastatic head and neck squamous cell carcinoma. Immune-related adverse events (irAEs) are well-described complications of PD-1 inh
Externí odkaz:
https://doaj.org/article/76da1043e30f40408f14b603cd550117
Autor:
Koichi Kitagawa, Maho Tatsumi, Mako Kato, Shota Komai, Hazuki Doi, Yoshiko Hashii, Takane Katayama, Masato Fujisawa, Toshiro Shirakawa
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss , Pp 592-603 (2021)
Cancer immunotherapy using immune-checkpoint inhibitors (ICIs) such as PD-1/PD-L1 inhibitors has been well established for various types of cancer. Monotherapy with ICIs, however, can achieve a durable response in only a subset of patients. There is
Externí odkaz:
https://doaj.org/article/3b9793af28f243d7872de85b30098864
Autor:
Takayuki Hamabata, Katsutsugu Umeda, Kagehiro Kouzuki, Takayuki Tanaka, Tomoo Daifu, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Shiro Baba, Hidefumi Hiramatsu, Mitsujiro Osawa, Akira Niwa, Megumu K. Saito, Yasuhiko Kamikubo, Souichi Adachi, Yoshiko Hashii, Akira Shimada, Hiroyoshi Watanabe, Kenji Osafune, Keisuke Okita, Tatsutoshi Nakahata, Kenichiro Watanabe, Junko Takita, Toshio Heike
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-4 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/b950f5eee1ed4eed9297ec002e679c2f
Autor:
Yoshiko Hashii, Yoshihiro Oka, Naoki Kagawa, Naoya Hashimoto, Hiroyuki Saitou, Syogo Fukuya, Mizuki Kanegae, Sayaka Ikejima, Yusuke Oji, Keiichi Ozono, Akihiro Tsuboi, Haruo Sugiyama
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Diffuse midline glioma (DMG) in children is a highly aggressive, malignant brain tumor that is fatal when relapsed. Wilms tumor 1 (WT1) is a high-priority antigen target for cancer immunotherapy. We hereby report on a pediatric patient who had DMG th
Externí odkaz:
https://doaj.org/article/1d662f20d7d34a838619aa5f8de91774
Autor:
Hideki Yoshida, Toshihiko Imamura, Akiko M Saito, Yoshihiro Takahashi, So-ichi Suenobu, Daiichiro Hasegawa, Takao Deguchi, Yoshiko Hashii, Hirohide Kawasaki, Mikiya Endo, Hiroki Hori, Nobuhiro Suzuki, Yoshiyuki Kosaka, Koji Kato, Keiko Yumura-Yagi, Junichi Hara, Megumi Oda, Atsushi Sato, Keizo Horibe, Japan Association of Childhood Leukemia Study
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136428 (2015)
Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase re
Externí odkaz:
https://doaj.org/article/c43cd903861e4e8594fb2a0500f84229
Autor:
Asahito Hama, Takashi Taga, Daisuke Tomizawa, Hideki Muramatsu, Daiichiro Hasegawa, Souichi Adachi, Nao Yoshida, Maiko Noguchi, Maho Sato, Keiko Okada, Katsuyoshi Koh, Tetsuo Mitsui, Yoshiyuki Takahashi, Takako Miyamura, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Yasuhiro Okamoto
Publikováno v:
British Journal of Haematology. 201:747-756